Literature DB >> 15390059

Nurr1 mutational screen in Parkinson's disease.

Eng-King Tan1, Henry Chung, Vandana R Chandran, Chris Tan, Hui Shen, Kenneth Yew, Ratnagopal Pavanni, Kathi-avelu Puvan, Meng-Cheong Wong, Mei-Lin Teoh, Yuan Yih, Yi Zhao.   

Abstract

We performed sequence analysis of all the exons and exon-intron boundaries in familial and young-onset Parkinson's disease (PD) in an Asian cohort. None of the patients carried any pathogenic mutations in the Nurr1 gene. We demonstrated a 5 to 10% prevalence of the intron 7 +33 C-->T variant among Malay and Indian PD and healthy controls, suggesting that this variant, which was previously described only in 1 Chinese patient, was not a silent mutation but a common polymorphic variant in some ethnic races. 2004 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15390059     DOI: 10.1002/mds.20246

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  6 in total

1.  Activation of Peroxisome Proliferator-Activated Receptor-α Increases the Expression of Nuclear Receptor Related 1 Protein (Nurr1) in Dopaminergic Neurons.

Authors:  Carl G Gottschalk; Avik Roy; Malabendu Jana; Madhuchhanda Kundu; Kalipada Pahan
Journal:  Mol Neurobiol       Date:  2019-05-24       Impact factor: 5.590

2.  Characterisation of a novel NR4A2 mutation in Parkinson's disease brain.

Authors:  P M A Sleiman; D G Healy; M M K Muqit; Y X Yang; M Van Der Brug; J L Holton; T Revesz; N P Quinn; K Bhatia; J K J Diss; A J Lees; M R Cookson; D S Latchman; N W Wood
Journal:  Neurosci Lett       Date:  2009-03-11       Impact factor: 3.046

Review 3.  The regulation and deregulation of Wnt signaling by PARK genes in health and disease.

Authors:  Daniel C Berwick; Kirsten Harvey
Journal:  J Mol Cell Biol       Date:  2013-10-09       Impact factor: 6.216

4.  A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C).

Authors:  Gaynor A Smith; Emily M Rocha; Thomas Rooney; Pascal Barneoud; Jesse R McLean; Jonathan Beagan; Teresia Osborn; Madeleine Coimbra; Yongyi Luo; Penelope J Hallett; Ole Isacson
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

5.  Efficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization.

Authors:  Maykel Cruz-Monteagudo; Fernanda Borges; Cesar Paz-Y-Miño; M Natália D S Cordeiro; Irene Rebelo; Yunierkis Perez-Castillo; Aliuska Morales Helguera; Aminael Sánchez-Rodríguez; Eduardo Tejera
Journal:  BMC Med Genomics       Date:  2016-03-09       Impact factor: 3.063

6.  Analysis of rare variants of autosomal-dominant genes in a Chinese population with sporadic Parkinson's disease.

Authors:  Ran Zheng; Chong-Yao Jin; Ying Chen; Yang Ruan; Ting Gao; Zhi-Hao Lin; Jia-Xian Dong; Ya-Ping Yan; Jun Tian; Jia-Li Pu; Bao-Rong Zhang
Journal:  Mol Genet Genomic Med       Date:  2020-08-14       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.